Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Posts 8.6-Percent Rise in Q4 Revenue as Profit Widens 250 Percent

NEW YORK (GenomeWeb News) — Beckman Coulter today said fourth-quarter revenues increased 8.6 percent as R&D spending receded 2.7 percent and profit jumped 250 percent.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $712 million from $655.5 million year over year.
 
Product-related revenue increased 8.1 percent to $104 million while service-related revenue was up 8.7 percent to $608 million.
 
R&D spending decreased slightly to $57.6 million from $59.2 million in the previous fourth quarter.
 
The company said profit increased to $62.3 million from $17.8 million in the year-ago period.
 
The company attributed the increase to smaller operating expenses. Specifically, in the fourth quarter in 2005 the company paid $32.9 million more in restructuring costs, had a $10.7 million “asset impairment” charge, and spent $11.4 million more in selling and administrative costs.
 
BC said it had around $75.2 million in cash and equivalents as of Dec. 31, 2006.
 
The company said it expects 2007 revenue to grow between 7 percent and 9 percent over 2006.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.